TrialJournal of diabetes2022

Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long-term follow-up of the ESCAPE study.

Minji Sohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.